INNOMIND
Live / Registered — Registered (as of 25 Nov 2025)
What this means for you
Registered since 25 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98372177
- Registration number
- 8043688
- Mark type
- Stylized text
- Filed
- 23 Jan 2024
- Published for opposition
- 01 Oct 2024
- Registered
- 25 Nov 2025
- Attorney of record
- Paulo A. de Almeida
Goods and services
- Class 005 — Pharmaceuticals: Medicines for human purposes, namely, medicines for the treatment of diabetes, obesity, cancer, tumors, cardiovascular diseases, colds, coughs, influenza, respiratory disorders and asthma, gastrointestinal disorders, genitourinary disorders, neurological disorders, allergic reactions, headaches, insomnia, bacterial disorders and eye diseases; Chemical preparations for pharmaceutical purposes, namely, for neurological system related diseases and disorders; Biological preparations for the treatment of neurological system related diseases; Pharmaceutical products for the treatment of central nervous system related diseases; Pharmaceutical preparations for the prevention and treatment of neurological disorders; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for peripheral nervous system; Tranquillizers; Cardiovascular pharmaceutical preparations; Antidepressants; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for treating diabetes; Ophthalmic preparations; Pain relief medication; Tumor suppressing agents; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders
Owner
- Luye Innomind Pharma Shijiazhuang Co., Ltd., Shijiazhuang city, CN
- Luye Innomind Pharma Shijiazhuang Co., Ltd., Shijiazhuang city, CN
- Luye Innomind Pharma Shijiazhuang Co., Ltd., Shijiazhuang city, CN
Prosecution history
- 25 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 05 Nov 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Nov 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Oct 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 19 May 2025 — USE AMENDMENT FILED
- 25 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 May 2025 — TEAS STATEMENT OF USE RECEIVED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Oct 2024 — PUBLISHED FOR OPPOSITION
- 11 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Aug 2024 — ASSIGNED TO EXAMINER
- 24 May 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED